Skip to content

Qualitative Research on Experience of Main Caregivers of Ovarian Cancer Patients during chemotherapy

Qualitative Research on Experience of Main Caregivers of Ovarian Cancer Patients during chemotherapy

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039930
Enrollment
Unknown
Registered
2020-11-14
Start date
2020-11-02
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Interventions

case series:no intervention

Sponsors

The First Bethune Hospital of Jinlin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The main caregivers of patients with ovarian cancer confirmed by clinicopathological examination who need chemotherapy after operation; 2. The main caregivers include spouse, children, parents, etc. they live with the patients during the care period; 3. Subjects over the age of 18 years old; subjects under the age of 70 years old, performing most of the patient care activities; 4. Subjects with normal cognition have normal communication ability and clear speech expression; 5. Patients with informed consent and their family members are willing to participate, and can cooperate and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Paid nursing workers; 2. Family members without mobile phone or other contact tools and unable to get in touch; 3. Family members of patients with serious mental or psychological disorders; 4. The caregiver or the patient refused to take part in the study.

Design outcomes

Primary

MeasureTime frame
The caregiver’s feeling of psychology and symptoms;

Countries

China

Contacts

Public ContactZhang Qi

The First Bethune Hospital of Jinlin University

zhangqiphd@gmail.com+86 13936595667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026